Sharp Health Plan
Tykerb (lapatinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 3 EA PER fill retail
  • Hemophilia (Factor XIII Deficiency):
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Dosing Limit(s): N/A
    Treatment Center Required: No

<< Return | Back to top